Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.

By A. Mitchell, Davy Vancampfort, K. Sweers, R. van Winkel, Weiping Yu, M. De Hert. Schizophrenia bulletin, 2013

1,003 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/78f8c08ff2cc0ee9b3450adaa771f05687f75193

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Psychiatry and Mental health

1. Brendon Stubbs
2. Christoph U. Correll
3. A. Mitchell

Citations in the corpus

• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders (2016, background): “Long-term physical health outcomes for people with schizophrenia and related disorders are poor (Galletly et al., 2012; Mitchell et al., 2013).”
• Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder (2015, background): “10) were more commonly met in patients with schizophrenia (17).”
• Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis (2015, methodology): “Previous meta-analyses (21-24) documented that people with SMI have an increased risk for developing MetS compared with the general population.”